acetilcisteína Бразилия - португалски - ANVISA (Agência Nacional de Vigilância Sanitária)

acetilcisteína

uniÃo quÍmica farmacÊutica nacional s/a - acetilcisteÍna - expectorantes balsamicos e mucolitico

Rozlytrek Европейски съюз - португалски - EMA (European Medicines Agency)

rozlytrek

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - agentes antineoplásicos - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Retsevmo Европейски съюз - португалски - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agentes antineoplásicos - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

CALMINEX DICLO Бразилия - португалски - ANVISA (Agência Nacional de Vigilância Sanitária)

calminex diclo

cosmed industria de cosmeticos e medicamentos s.a. - diclofenaco dietilamÔnio - antinflamatorios

Pregabalina Aurovitas 200 mg Cápsula Португалия - португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

pregabalina aurovitas 200 mg cápsula

generis farmacêutica, s.a. - pregabalina - cápsula - 200 mg - pregabalina 200 mg - pregabalin - genérico - duração do tratamento: longa duração